Ivan Merelli

Affiliated with

Research Area

Biography

Ivan Merelli has not added Biography.
If you are Ivan Merelli and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 1	2023

Other Publications

Article	Year
High parathyroid hormone concentration in tenofovir-treated patients are due to inhibition of calcium-sensing receptor activity. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie\| PubMed ID: 29136775	2018
Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response. Cell stem cell\| PubMed ID: 30905619	2019
γ-TRIS: a graph-algorithm for comprehensive identification of vector genomic insertion sites. Bioinformatics (Oxford, England)\| PubMed ID: 31589304	2020
Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis. Haematologica\| PubMed ID: 31949009	2021
Hematopoietic stem cell function in β-thalassemia is impaired and is rescued by targeting the bone marrow niche. Blood\| PubMed ID: 32344432	2020
Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking. Nature biotechnology\| PubMed ID: 32601433	2020
Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome. EMBO molecular medicine\| PubMed ID: 33475257	2021
BAR-Seq clonal tracking of gene-edited cells. Nature protocols\| PubMed ID: 34031609	2021
Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease. Blood\| PubMed ID: 34077954	2021
Premature Senescence and Increased Oxidative Stress in the Thymus of Down Syndrome Patients. Frontiers in immunology\| PubMed ID: 34140950	2021
Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis. Nature communications\| PubMed ID: 34315896	2021
Myeloid cell-based delivery of IFN-γ reprograms the leukemia microenvironment and induces anti-tumoral immune responses. EMBO molecular medicine\| PubMed ID: 34459560	2021
Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse. Cancer discovery\| PubMed ID: 35255120	2022
Identification of a retinoic acid-dependent haemogenic endothelial progenitor from human pluripotent stem cells. Nature cell biology\| PubMed ID: 35484246	2022
Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency. European journal of immunology\| PubMed ID: 35562849	2022
Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse models. Science translational medicine\| PubMed ID: 35857642	2022
Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 35982622	2023
Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells. Cell stem cell\| PubMed ID: 36206730	2022
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency. Frontiers in immunology\| PubMed ID: 36248833	2022
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production. Rheumatology (Oxford, England)\| PubMed ID: 36802235	2023
Protocol to differentiate monolayer human induced pluripotent stem cells into inflammatory responsive astrocytes. STAR protocols\| PubMed ID: 36881505	2023
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia. Nature communications\| PubMed ID: 36890137	2023